BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a Phase 2a study which is being conducted in healthy volunteers in order to evaluate the comparative reduction of Propionibacterium acnes in-vivo following once daily topical administration of BPX-01 Minocycline 1% Topical Gel (BPX-01) or BPX-01 Vehicle control.
Epistemonikos ID: 189dd7e91ebcb57c9707d5d0b5cc6f1e4294a657
First added on: May 12, 2024